Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    Statera Pharmaceuticals treatment for Covid-19 Long-Haulers

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021
    industrial Hemp, Generation Hemp, GENH, Hemp, Cannabis, Textiles, Manufacturing,

    Why Is There a Renewed Interest in Hemp by Textile and Manufacturing Companies?

    August 6, 2021
    What's the difference between Marijuana, Cannabis and Hemp -- industrial Hemp, CBD, Farm Bill, Agricultural Act, Generation Hemp, GENH

    Cannabis Investors Should Know the Difference Between Marijuana and Hemp

    July 19, 2021
  • Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,
    Business,  Benzinga,  Finance,  Health,  IoT,  Medtech,  Technology,  Wearable Devices

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another.  Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…

    read more
    Jessica N. Abraham Comments Off on Biotricity Reports Q1 Earnings at 290% for FY2022

    You May Also Like

    ADHD, ADD, Moms with ADD, Business, Break, Holiday Season, Family, Productivity, Deadlines, Schedule, Planning

    Staying Productive During the Holiday Season

    December 24, 2020
    Workforce Optimization Software, quality recording, recording software, center recording, voip, call quality, logging, Coordinated Systems, quality recording solutions

    eBay Enterprises Simplifies Omnichannel Controls

    December 3, 2015
    Carnot® Compressor, National Science Foundation (NSF) and the California Energy Commission (CEC)

    Oil-free Air In, Oil-free Air Out: Solving Problems in Compression and the Environment

    December 14, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.